Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Zeitschrift für Gerontologie und Geriatrie 8/2018

07.11.2017 | Original contribution

Gender differences in mortality among statin users aged 80 years or more

verfasst von: MD Dan Justo, MD Mark Tchernichovsky, MD Anjelika Kremer, MD Erel Joffe, MD Shany Sherman, MD Marina Ioffe, MD Haim Mayan

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about the prognosis associated with statin therapy and its gender differences in older adults aged ≥80 years.

Objective

To study the mortality and survival associated with statin therapy and their gender differences in older adults aged ≥80 years.

Method

This was a historical prospective study conducted at a tertiary medical center. The medical charts of all older adults aged ≥80 years who had been admitted to a single internal medicine department during 1 year were reviewed. All-cause 3‑year mortality and survival rates following hospital admission in men and in women using statins were investigated.

Results

The final cohort included 216 patients: 122 (56.5%) women, mean age 85.3 ± 3.9 years. Overall, 66 (53.2%) women and 58 (46.8%) men used statins for 3 years or more following hospital admission. During this time 48 (39.3%) women and 48 (51.1%) men died. The all-cause 3‑year mortality rates were significantly lower only in women who had used statins compared with women who had not used statins (24.2% vs. 57.1%; relative risk = 0.2; 95% confidence interval 0.1–0.5; p < 0.0001). The 3‑year cumulative survival rates were significantly higher in women who had used statins as part of primary as well as secondary cardiovascular prevention (p < 0.0001 and p = 0.014, respectively). A Cox regression analysis showed that statin therapy was independently associated with low 3‑year cumulative mortality rates in women (hazard ratio=0.3; 95% confidence interval=0.1–0.6; p = 0.001).

Conclusion

In older adults aged ≥80 years, statin therapy is associated with high 3‑year cumulative survival rates only in women.
Literatur
1.
Zurück zum Zitat Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE (2013) Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol 20(4):641–657 CrossRefPubMed Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE (2013) Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol 20(4):641–657 CrossRefPubMed
2.
Zurück zum Zitat Depp CA, Jeste DV (2006) Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 14:6–20 CrossRefPubMed Depp CA, Jeste DV (2006) Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 14:6–20 CrossRefPubMed
3.
Zurück zum Zitat Eaton CB, Lapane KL, Murphy JB, Hume AL (2002) Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1‑year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc 50:1389–1395 CrossRefPubMed Eaton CB, Lapane KL, Murphy JB, Hume AL (2002) Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1‑year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc 50:1389–1395 CrossRefPubMed
4.
Zurück zum Zitat Gränsbo K, Melander O, Wallentin L, Lindbäck J, Stenestrand U, Carlsson J, Nilsson J (2010) Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol 55:1362–1369 CrossRefPubMed Gränsbo K, Melander O, Wallentin L, Lindbäck J, Stenestrand U, Carlsson J, Nilsson J (2010) Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol 55:1362–1369 CrossRefPubMed
5.
Zurück zum Zitat Strandberg TE, Pitkala KH, Tilvis RS (2008) Statin treatment is associated with clearly reduced mortality risk of cardiovascular patients aged 75 years and older. J Gerontol A Biol Sci Med Sci 63:213–214 CrossRefPubMed Strandberg TE, Pitkala KH, Tilvis RS (2008) Statin treatment is associated with clearly reduced mortality risk of cardiovascular patients aged 75 years and older. J Gerontol A Biol Sci Med Sci 63:213–214 CrossRefPubMed
6.
Zurück zum Zitat Allen Maycock CA, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Pearson RR, Li Q, Anderson JL, Intermountain Heart Collaborative Study (2002) Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 40:1777–1785 CrossRefPubMed Allen Maycock CA, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Pearson RR, Li Q, Anderson JL, Intermountain Heart Collaborative Study (2002) Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 40:1777–1785 CrossRefPubMed
7.
Zurück zum Zitat Jacobs JM, Cohen A, Ein-Mor E, Stessman J (2013) Cholesterol, statins, and longevity from age 70 to 90 years. J Am Med Dir Assoc 14:883–888 CrossRefPubMed Jacobs JM, Cohen A, Ein-Mor E, Stessman J (2013) Cholesterol, statins, and longevity from age 70 to 90 years. J Am Med Dir Assoc 14:883–888 CrossRefPubMed
8.
Zurück zum Zitat Rothschild DP, Novak E, Rich MW (2016) Effect of statin therapy on mortality in older adults hospitalized with coronary artery disease: a propensity-adjusted analysis. J Am Geriatr Soc 64:1475–1479 CrossRefPubMed Rothschild DP, Novak E, Rich MW (2016) Effect of statin therapy on mortality in older adults hospitalized with coronary artery disease: a propensity-adjusted analysis. J Am Geriatr Soc 64:1475–1479 CrossRefPubMed
9.
Zurück zum Zitat Lloyd SM, Stott DJ, de Craen AJ, Kearney PM, Sattar N, Perry I, Packard CJ, Briggs A, Marchbank L, Comber H, Jukema JW, Westendorp RG, Trompet S, Buckley BM, Ford I (2013) Long-term effects of statin treatment in elderly people: extended follow-up of the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). PLOS ONE 8:e72642 CrossRefPubMedPubMedCentral Lloyd SM, Stott DJ, de Craen AJ, Kearney PM, Sattar N, Perry I, Packard CJ, Briggs A, Marchbank L, Comber H, Jukema JW, Westendorp RG, Trompet S, Buckley BM, Ford I (2013) Long-term effects of statin treatment in elderly people: extended follow-up of the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). PLOS ONE 8:e72642 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM (2010) Rosuvastatin for primary prevention in older persons with elevated C‑reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med 152:488–496 CrossRefPubMedPubMedCentral Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM (2010) Rosuvastatin for primary prevention in older persons with elevated C‑reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med 152:488–496 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Farahani P (2014) Sex/gender disparities in randomized controlled trials of statins: the impact of awareness efforts. Clin Invest Med 37:E163 CrossRefPubMed Farahani P (2014) Sex/gender disparities in randomized controlled trials of statins: the impact of awareness efforts. Clin Invest Med 37:E163 CrossRefPubMed
12.
Zurück zum Zitat Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Pt B):2889–2934 CrossRefPubMed Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Pt B):2889–2934 CrossRefPubMed
13.
Zurück zum Zitat Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA Group (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248–2261 CrossRefPubMed Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA Group (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248–2261 CrossRefPubMed
14.
Zurück zum Zitat Allen M, Canadian Academic Detailing Collaboration (2006) Statins in primary prevention: uncertainty in women, elderly. Am Fam Physician 73:973–974 PubMed Allen M, Canadian Academic Detailing Collaboration (2006) Statins in primary prevention: uncertainty in women, elderly. Am Fam Physician 73:973–974 PubMed
15.
Zurück zum Zitat Owen A (2006) Life expectancy of elderly and very elderly patients with chronic heart failure. Am Heart J 151:1322.e1–1322.e4 CrossRef Owen A (2006) Life expectancy of elderly and very elderly patients with chronic heart failure. Am Heart J 151:1322.e1–1322.e4 CrossRef
16.
Zurück zum Zitat Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A (2007) Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr 26:84–90 CrossRefPubMed Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A (2007) Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr 26:84–90 CrossRefPubMed
Metadaten
Titel
Gender differences in mortality among statin users aged 80 years or more
verfasst von
MD Dan Justo
MD Mark Tchernichovsky
MD Anjelika Kremer
MD Erel Joffe
MD Shany Sherman
MD Marina Ioffe
MD Haim Mayan
Publikationsdatum
07.11.2017
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 8/2018
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-017-1335-y